September 25, 2020

The Niche

Knoepfler lab stem cell blog

Cas9 NHEJ

9 min read

I’m doing a series of interviews with leaders in the field on human germline modification with the first interview in this series with George Church and today’s second in this series is a conversation I had with Dr. Jennifer Doudna, a pioneer in CRISPR-Cas9 technology. Doudna is a Professor in MCB and Chemistry as well as Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences at UC Berkeley. She is also an HHMI Investigator. You can read more about the Doudna lab’s research here. …Read More

2 min read

CRISPR Cas9 is a relatively new, powerful approach to gene editing and genetic modification more generally. In the relatively short window of time in which this technology has been widely available for gene editing applications it has already evolved rapidly to become more powerful. Here are some new papers of interest on this technology. With many CRISPR papers every week these days there are probably other great papers too. What are your favorite recent papers in this area lately? How much off-site targeting is …Read More